Product Description: XL-281 (BMS-908662) is an orally active inhibitor for RAF kinase, with IC50s of 2.6, 4.5 and 6 nM, for CRAF, B-RAF, and B-RAFV600E, respectively. XL-281 exhibits antitumor activity[1].
Applications: Cancer-Kinase/protease
Formula: C24H19ClN4O4
References: [1]Dickson MA, et al., Phase I study of XL281 (BMS-908662), a potent oral RAF kinase inhibitor, in patients with advanced solid tumors. Invest New Drugs. 2015 Apr;33(2):349-56.
CAS Number: 870603-16-0
Molecular Weight: 462.89
Research Area: Cancer
Target: Raf